185 related articles for article (PubMed ID: 37863080)
21. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A
Blood Cells Mol Dis; 2022 Nov; 97():102689. PubMed ID: 35780678
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
24. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
25. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
26. The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis.
Verhaegh PL; Moris W; Koek GH; van Deursen CT
Liver Int; 2016 Oct; 36(10):1535-9. PubMed ID: 26992127
[TBL] [Abstract][Full Text] [Related]
27. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations].
Fernández-Mosteirín N; Salvador-Osuna C; García-Erce JA; Orna E; Pérez-Lungmus G; Giralt M
Med Clin (Barc); 2006 Sep; 127(11):409-12. PubMed ID: 17020684
[TBL] [Abstract][Full Text] [Related]
28. Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.
Rombout-Sestrienkova E; Koek GH; Neslo R; van Kraaij M; Menheere PP; Masclee A; Swinkels DW
J Clin Apher; 2016 Dec; 31(6):564-570. PubMed ID: 26878994
[TBL] [Abstract][Full Text] [Related]
29. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group.
Corti P; Ferrari GM; Faraguna MC; Capitoli G; Longo F; Corradini E; Casini T; Boscarol G; Pinto VM; Ghilardi R; Russo G; Colombatti R; Mariani R; Piperno A
Br J Haematol; 2024 Jan; 204(1):306-314. PubMed ID: 37990447
[TBL] [Abstract][Full Text] [Related]
30. TFR2-related haemochromatosis in the Netherlands: a cause of arthralgia in young adulthood.
Peters TM; Meulders AF; Redert K; Cuijpers ML; Rennings AJ; Janssen MC; Blijlevens NM; Swinkels DW
Neth J Med; 2017 Mar; 75(2):56-64. PubMed ID: 28276324
[TBL] [Abstract][Full Text] [Related]
31. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
32. Haemochromatosis.
Adams PC; Barton JC
Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
[TBL] [Abstract][Full Text] [Related]
33. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
34. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening.
Gleeson F; Ryan E; Barrett S; Crowe J
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409
[TBL] [Abstract][Full Text] [Related]
35. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
36. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection.
Le Gac G; Scotet V; Gourlaouen I; L'Hostis C; Merour MC; Karim Z; Deugnier Y; Bardou-Jacquet E; Lefebvre T; Assari S; Ferec C
Aliment Pharmacol Ther; 2022 Apr; 55(8):1016-1027. PubMed ID: 35122291
[TBL] [Abstract][Full Text] [Related]
38. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).
Ong SY; Dolling L; Dixon JL; Nicoll AJ; Gurrin LC; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Kava J; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
BMJ Open; 2015 Aug; 5(8):e008938. PubMed ID: 26270952
[TBL] [Abstract][Full Text] [Related]
39. Haemochromatosis in a kidney transplant recipient: a case report.
Zakrocka I; Baranowicz-Gąszczyk I; Załuska W
BMC Nephrol; 2021 May; 22(1):201. PubMed ID: 34051741
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]